Phase 3 Insulin Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 2Phase 3
Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers
PharmacokineticsPharmacodynamicsInsulin Aspart
Amphastar Pharmaceuticals, Inc.60 enrolled1 locationNCT07560150
Recruiting
Phase 3
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Tumor Hyperinsulinism (Tumor HI)
Rezolute16 enrolled13 locationsNCT06881992
Recruiting
Phase 3
18F-DOPA II - PET Imaging Optimization
Neuroendocrine TumorsBrain TumorNeuroblastoma+3 more
University of Alberta800 enrolled1 locationNCT04706910
Recruiting
Phase 3
Effect of Metformin Use on Weight Loss in Obese, Non-diabetic People (MOWRI)
Insulin ResistanceObesity and Cardiovascular RiskObesity (Body Mass Index >30 kg/m2)
University Of Nigeria Teaching Hospital220 enrolled2 locationsNCT07297290
Recruiting
Phase 3
Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance
Insulin ResistanceObesity, Childhood
University of Alberta90 enrolled1 locationNCT04578652
Recruiting
Phase 3
Pregnancy Outcomes: Effects of Metformin Study (POEM Study)
Insulin ResistanceGestational Diabetes
Bethesda Diabetes Research Center500 enrolled4 locationsNCT02947503
Completed
Phase 2Phase 3
CF-IDEA (Cystic Fibrosis - Insulin Deficiency, Early Action): Randomised controlled trial of once-daily insulin detemir in patients with cystic fibrosis and early insulin deficiency
Insulin DeficiencyCystic Fibrosis
Sydney Children's Hospital100 enrolled1 locationACTRN12611000068965